Qube Research & Technologies LTD Merck & Co., Inc. Transaction History
Qube Research & Technologies LTD
- $91.4 Billion
- Q3 2025
A detailed history of Qube Research & Technologies LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 2,063,967 shares of MRK stock, worth $192 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
2,063,967
Previous 4,022,464
48.69%
Holding current value
$192 Million
Previous $318 Million
45.6%
% of portfolio
0.19%
Previous 0.34%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,875Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...